Get started

Aurobindo

AUROPHARMA may break downward channelAURO Pharma is trading downward parallel channel since last two year. Also form bullish RSI divergence in weekly timeframe. So, it can buy whenever breaks downward channel for long term investment, or even more than 5-year investment can be done average in this channel and wait for breakout. This is as per my best knowledge, we are not advising anyone to buy or sell, consult your personal advisor for investment advice. No personal holding in this stock as on today.
NSE:AUROPHARMALong
by P_hetalben
Aurobindo Pharma Trade Plan: Target 550+ with Little RiskAurobindo Pharma has recently shown a strong growth recovery from its bottom, offering a potential trading opportunity with minimal risk. Our analysis reveals the activation of a harmonic Bat Pattern, which suggests a target of 552 with an entry range of 474-482 and a stop loss of 444. By leveraging this trade plan, traders can potentially profit from the current market conditions while effectively managing their risk exposure. As always, traders are advised to closely monitor price movements and adjust their strategy accordingly.
NSE:AUROPHARMA
by karuneshBajpai2
Aurobindo Pharma: Chart AnalysisAurobindo Pharma 21 day EMA around 528 63 day EMA around 543 252 day EMA around 623 One may consider to buy the stock for target of 580 - 588 / 618 - 622 Keep a SL at 525 Take care & safe trading...!!! Disclaimer -The view expressed here is my personal view - Past performance is not a guarantee for future predictions - I have been wrong in the past and can be wrong again in future too - Use this for educational purpose - Any decision you take, you need to take responsibility for the same - It's your hard earned money. Treat it wisely - Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance - if trading in F&O, understand that F&O trading involves risk - Do take proper risk management measures - Do your own analysis and consult your financial adviser if need be
NSE:AUROPHARMALong
by indiamarketoutlook
1
Aurobindo Pharma: Will the medicine work this time???Aurobindo Observations - has been sideways since May 16, 2022 - stock has moved past 20 day EMA - stock has crossed 50 day EMA - the stock is on the verge of breaking range bound channel - sustaining above 552 is going to be the key -target for the set up 612 / 630 Consider buying 570 Call Option at cmp & /or on dips in Spot Aurobindo Pharma around 552 Target 33 / 42 Do proper risk management Disclaimer - The view expressed here is my personal view - Past performance is not a guarantee for future predictions - Use this for educational purpose - Any decision you take, you need to take responsibility for the same - It's your hard earned money. Treat it wisely - Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance - if trading in F&O, understand that F&O trading involves risk - Do take proper risk management measures - Do your own analysis and consult your financial adviser if need be
NSE:AUROPHARMALong
by indiamarketoutlook
2
Aurobindo Pharma: Chart set up and trading strategy Observations - Line of Support at 680 - 20 day EMA and 50 day EMA around 668 and 664 respectively - 200 day EMA around 728 Momentum may come once the stock gives a close above 728 - 740 zone 20 day and 50 EMA might provide Support Trading strategy: Given the set up, one may consider Selling Aurobindo Pharma 28 April expiry 680 Put option currently around 26 The strategy has a 12% yield potential and provides protection against loss for a fall up to 654 till 28 April 2022. Take care & safe trading...!!! Disclaimer - The view expressed here is my personal view - Past performance is not a guarantee for future predictions - Use this for educational purpose - Any decision you take, you need to take responsibility for the same - It's your hard earned money. Treat it wisely - Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance - if trading in F&O, understand that F&O trading involves risk - Do take proper risk management measures - Do your own analysis and consult your financial adviser if need be
NSE:AUROPHARMALong
by indiamarketoutlook
AuroPharma: Resistance turns to SupportAuroPharma has pulled back to a level which was previously a resistance zone near 600. This zone may act as a support now because of a basic principle of support and resistance. "A resistance once broken on the upside may turn into a support later on. Conversely, a support once broken down may act as resistance later on". The level 600 coincides with the 61.8% retracement level as visible on the chart. So that is another plus point. It could be a medium to long term buy with SL below 590 for targets of 797 and then 877. Stop can be trailed higher to 643 if the trend resumes on the upside. It could also be taken as short term buy with SL below 643 for a target of 730 Disclaimer: Not Sebi registered No personal investment in the stock
NSE:AUROPHARMALong
by Bravetotrade
3
Aurobindo Pharma: Chart set up & important levelsObservations - the stock has given a breakout in the short term on December 8, 2021 - the stock has given a breakout in the medium term on December 22, 2021 - 20 day EMA cross over above 50 day EMA on Dec 29, 2021 Is Aurobindo finally recovering from the illness (that took it down from 1063 odd levels to 620 odd levels) and roaring to get back??? A final push above 736 could be the key to unlock its movement on the upside 780 is 200 day EMA Long term Trendline resistance around 824 currently. Sustaining Above that, gates would open up further upside towards 905-940 odd levels Do note: The stock has tested our patience a lot in the last 3 months and there could be personal bias in here. Take care & safe trading...!!! Like & Follow for more such trading ideas Disclaimer - The view expressed here is my personal view - Past performance is not a guarantee for future predictions - Use this for educational purpose - Any decision you take, you need to take responsibility for the same - It's your hard earned money. Treat it wisely - Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance - if trading in F&O, understand that F&O trading involves risk - Do take proper risk management measures - Do your own analysis and consult your financial adviser if need be
NSE:AUROPHARMALong
by indiamarketoutlook
Aurobindo Pharma: Get well soonAurobindo Pharma - The stock has been an underperformer since May 2021 - Was the recent breakdown below 680 just a shakeout of weak hands or would it get resisted again? - We are soon to find out... The stock is near make or break zone. Momentum might be seen on sustaining above 712 Note: In our last stint with Aurobindo Pharma it did not work out that well, so due your due diligence 🙏 Take care & safe trading....!!! Disclaimer - The view expressed here is my personal view - Past performance is not a guarantee for future predictions - Use this for educational purpose - Any decision you take, you need to take responsibility for the same - It's your hard earned money. Treat it wisely - Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance - if trading in F&O, understand that F&O trading involves risk - Do take proper risk management measures - Do your own analysis and consult your financial adviser if need be
NSE:AUROPHARMALong
by indiamarketoutlook
Aurobindo Pharma Technical and Fundamental AnalysisTechnical Analysis Aurobindo Pharma has taken support at upper range of support box(630). It can move upwards after taking support at 630 price level. It is good time to accumulate share at current levels for long term. Fundamental Analysis Current PE : 7.45 (Undervalued in comparison to peer Pharma stocks) Sector PE : 38.7 Below data for previous 5 years. Revenue Growth : 15.2% Sector Revenue Growth : 6.96% Market share increased from 7.65% to 11% Net income growth : 21.4% Sector Net income growth : 8%
NSE:AUROPHARMALong
by k2iadvisory
1
Aurobindo Pharma: Dragonfly doji and Gravestone doji around 712 This is a follow up. In our earlier post we had suggested the need of holding 738-712 odd levels. Now on weekly charts we see dragonfly doji and then later gravestone doji both forming around 712 odd levels The set up has a target of 758 / 805 / 820 odd levels Keep a SL at 708 __________________________________________________________________________________________________________ F&O Strategy that may be considered Synthetic Long Position Buy Aurobindo 700 Call option cmp around 45 Sell Aurobindo 800 Call Option cmp around 7 Breakeven at 738 Take care & safe trading Disclaimer - The view expressed here is my personal view - Past performance is not a guarantee for future predictions - Use this for educational purpose - Any decision you take, you need to take responsibility for the same - It's your hard earned money. Treat it wisely - Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance - if trading in F&O, understand that F&O trading involves risk - Do take proper risk management measures - Do your own analysis and consult your financial adviser if need be Take care & safe trading
NSE:AUROPHARMALong
by indiamarketoutlook
Aurobindo Pharma - LongAurobindo Pharma - Long Buy : ₹ 697 - ₹ 730 Target: ₹ 768.05, ₹ 853.15, ₹ 903.6, Support: ₹ 673.5 Trade and Invest Wisely with your own knowledge! Good Luck! You can also see my other stock analysis and the results in my profile ideas. Please follow me , If you would like to see more ideas on winning stocks. **Disclaimer: I am NOT a SEBI registered consultant/Advisor. It is completely my view and opinion. My intention is not to provide any financial advice, training advice, or any type of advices or any recommendations on stock/Forex/Coin buying or selling. Please do your own research and consult with your financial advisor before taking any action. I am not responsible for any of your action on buying or selling or holding the above mentioned stock or/and index or/and Forex or/and coins . ***
NSE:AUROPHARMALong
by pmosesoliver